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Estimating the incidence of breast cancer in 
Africa: a systematic review and meta-analysis
Background Breast cancer is estimated to be the most com-
mon cancer worldwide. We sought to assemble publicly 
available data from Africa to provide estimates of the inci-
dence of breast cancer on the continent.
Methods A systematic search of Medline, EMBASE, Global 
Health and African Journals Online (AJOL) was conducted. 
We included population- or hospital-based registry studies 
on breast cancer conducted in Africa, and providing esti-
mates of the crude incidence of breast cancer among wom-
en. A random effects meta-analysis was employed to deter-
mine the pooled incidence of breast cancer across studies.
Results The literature search returned 4648 records, with 
41 studies conducted across 54 study sites in 22 African 
countries selected. We observed important variations in re-
ported cancer incidence between population- and hospi-
tal-based cancer registries. The overall pooled crude inci-
dence of breast cancer from population-based registries was 
24.5 per 100 000 person years (95% confidence interval 
(CI) 20.1-28.9). The incidence in North Africa was higher 
at 29.3 per 100 000 (95% CI 20.0-38.7) than Sub-Saharan 
Africa (SSA) at 22.4 per 100 000 (95% CI 17.2-28.0). In 
hospital-based registries, the overall pooled crude incidence 
rate was estimated at 23.6 per 100 000 (95% CI 18.5-28.7). 
SSA and Northern Africa had relatively comparable rates at 
24.0 per 100 000 (95% CI 17.5-30.4) and 23.2 per 100 000 
(95% CI 6.6-39.7), respectively. Across both registries, in-
cidence rates increased considerably between 2000 and 
2015.
Conclusions The available evidence suggests a growing in-
cidence of breast cancer in Africa. The representativeness of 
these estimates is uncertain due to the paucity of data in 
several countries and calendar years, as well as inconsisten-
cy in data collation and quality across existing cancer regis-
tries.
Electronic supplementary material: 




Cancer is a leading cause of morbidity and mortality among 
women globally, accounting for about 17.5 million cancer cases 
and 9 million deaths in 2015 [1]. Breast cancer is now ranked 
the most common cancer worldwide, increasing from 1.7 mil-
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sights into the epidemiology and risks associated with breast cancer have seen relative improvements in 
the response to breast cancer across population groups, particularly in high-income settings [3]. Howev-
er, in Africa and many low- and middle-income countries (LMICs), several challenges including poor 
health infrastructure, incomplete vital registrations, lack of population awareness, delayed health seeking 
behavior and low levels of female education and empowerment have led to high mortality from breast 
cancer [4], and also engendered a complex barrier to improving public health response to breast cancer 
in these settings [5].
The International Agency for Cancer Research (IARC) estimated that the incidence of breast cancer ranged 
from 27 per 100 000 women in central Africa to 39 per 100 000 women in southern Africa in 2012 [6]. 
Although, the incidence of breast cancer appears to be relatively low in Sub-Saharan Africa (SSA), surviv-
al from the disease is also generally poor in the region, with high mortality recorded in many settings 
[6,7]. The poor survival of breast cancer patients in SSA has been associated with late presentation, poor 
health care infrastructure and lack of adequate funding, amidst other competing public health challeng-
es [5]. Moreover, in isolated SSA countries with relatively good breast cancer care services, inequity and 
unaffordability of the services provided have been widely reported [5,8]. Consequently, late presentations 
and advanced stages at diagnosis of several breast cancer cases have been prevalent, likely explaining the 
higher mortality rates reported [7]. With ageing, population growth, and adoption of unhealthy lifestyles, 
the burden of breast cancer is projected to double in Africa by 2030 [9], especially in the absence of ef-
fective public health policies and interventions [9]. See Box 1 for an outline of what is already known, 
and what this study adds.
Breast cancer prevention and control in Africa is relatively limited, owing in part to a lack of reliable ep-
idemiologic risk factor data and information from which evidence-based interventions could have been 
developed [10,11]. For example, out of 46 World Health Organization (WHO) member states in SSA, 
only 20 (43.4%) have active cancer registries [12], spanning a wide range of coverage and completeness. 
These registries are poorly funded, largely limited to specific sub-national population groups (or even not 
population-based), and often do not meet standards required for active collation of cancer data [12]. 
Moreover, IARC also reported that due to lack of data on cancer incidence and mortality across develop-
ing countries, cancer estimates in these countries have been derived from frequency data or rates from 
neighboring countries with contextual similarities [9]. These efforts have no doubt contributed to the un-
derstanding of cancer burden in these settings [13]. However, intensifying ongoing efforts in the active 
collation of data from population- and hospital-based cancer registries across Africa and many developing 
countries may encourage further cancer-related research activities toward improving the overall represen-
tativeness of estimates provided [14,15]. Based on publicly available data, we estimated the incidence of 
breast cancer in Africa separately from population- and hospital-based cancer registries. We also exam-
ined the potential implication of the quality of data available from these registries on future responses to 
breast cancer in the region.
Box 1. About the study
What is already known?
The International Association of Cancer Registries (IACR) has been the main sources of cancer data in Africa, 
particularly by aiding African countries towards establishment of cancer registries. North Africa appears to have 
more robust data on cancer, with estimated incidence rates of breast cancer across North African states compa-
rable to some high-income settings. In SSA, current reports reveal an increasing number of breast cancer cases 
diagnosed in the ages 35-49 years, with many presenting at advanced late-stage disease. Largely, data availability 
remains an ongoing limitation in understanding and estimating the incidence of breast cancer on the African 
continent.
What this study adds
This study provides the first systematic review and meta-analysis of publicly available evidence on the incidence 
of female breast cancer in Africa. There is limited data on cancer in Africa, particularly in Central Africa; only 22 
African countries were included in this study. Population-based cancer registries remain the main sources of data 
on breast cancer in Africa as these provided 67% of all data points. Our estimated incidence of breast cancer in-
creased between 2000 and 2015 across both registries, suggestive of a rising breast cancer incidence in Africa. 
The mean age of populations covered ranged from 30.6 to 60.8 years, with over 33% and 81% of population in 
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METHODS
Search strategy and data sources
We conducted an initial scoping literature search to identify Medical Subject Headings (MESH) and rel-
evant keywords, following which a final search strategy was developed. We conducted a systematic search 
of Medline, EMBASE, Global Health and African Journals Online (AJOL), with search dates set from Jan-
uary 1980 to December 2016. We also conducted additional searches of Google Scholar, and websites of 
the International Association of Cancer Registries (IACR) and WHO African Region (AFRO). We equally 
reviewed the “GLOBOCAN studies” [6,9,16], “Cancer Incidence in Five Continents (CI5) series” [17], and 
“Cancer in Africa: Epidemiology and Prevention”[18] for more studies or additional data for studies already 
selected. Reference lists of initially selected studies were further hand-searched. The list of African coun-
tries was based on the World Bank list of economies [19] (Table 1).
Selection criteria
We included population-based or hospital-based cancer registry studies on breast cancer conducted pri-
marily on African population groups, and providing crude estimates of the cases or incidence of breast 
cancer among women in the population over a specified period. Studies were included if they were com-
pleted on or after the year 2000, to give a fair representation of the current burden. Hospital-based stud-
ies that only reported cases of breast cancer were also included if they provided sufficient information on 
the reference population to allow an estimation of the population or person-years at risk. We excluded 
studies on non-human subjects, and those that were mainly reviews, case reports, opinions or editorials. 
No language restrictions were applied.
Confirmation of breast cancer diagnosis
We included studies that identified breast cancer based on histological diagnosis with or without i) clin-
ical evaluation by a physician, ii) radiological investigations (mammography, breast ultrasound, comput-
ed tomography scan or magnetic resonance imaging), iii) laboratory tests (estrogen or progesterone re-
ceptor (ER or PR) status, the human epidermal growth factor receptor 2 (HER2) status, and breast cancer 
antigen (BRCA1 or BRCA2) or iv) community reported cases.
Quality criteria
Each study was assessed for quality according to a set of five (5) predefined criteria. The first criterion 
was based on the cancer registration process. This considered how cancer registries collated data and the 
approach employed for data ascertainment. The second considered the coding criteria employed across 
studies to determine if the reported cancer types were classified according to the primary anatomic site 
Table 1. Search terms for studies on breast cancer in Africa
Number SearcheS
1
africa/ or africa, northern/ or algeria/ or egypt/ or libya/ or morocco/ or africa, central/ or cameroon/ or central african 
republic/ or chad/ or congo/ or “democratic republic of the congo”/ or equatorial guinea/ or gabon/ or africa, eastern/ or 
burundi/ or djibouti/ or eritrea/ or ethiopia/ or kenya/ or rwanda/ or somalia/ or sudan/ or tanzania/ or uganda/ or africa, 
southern/ or angola/ or botswana/ or lesotho/ or malawi/ or mozambique/ or namibia/ or south africa/ or swaziland/ or 
zambia/ or zimbabwe/ or africa, western/ or benin/ or burkina faso/ or cape verde/ or cote d'ivoire/ or gambia/ or ghana/ 
or guinea/ or guinea-bissau/ or liberia/ or mali/ or mauritania/ or niger/ or nigeria/ or senegal/ or sierra leone/ or togo/
2 exp vital statistics/ or exp incidence/
3 (incidence* or prevalence* or morbidity or mortality).tw.
4 (disease adj3 burden).tw.
5 exp “cost of illness”/
6 exp quality-adjusted life years/
7 QALY.tw.
8 Disability adjusted life years.mp.
9 (initial adj2 burden).tw.
10 exp risk factors/
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12 exp breast cancer/
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(topography) or cellular characteristics (morphology—histology, behaviour, and grade) using the inter-
national classification of diseases (ICD) and oncology (ICD-O) guidelines [20-22]. The third assessed how 
population or person-years at risk were generated in each study. The fourth and fifth criteria checked 
whether the population covered in each study was representative of the target (subnational) and nation-
al populations, respectively. Each criterion was scored one (1), and studies were finally graded as high (4-
5), moderate (2-3) or low (0-1) quality based on the number of criteria they met (Table S1 in Online Sup-
plementary Document). All low-quality studies were excluded from the review.
Data extraction
Two reviewers (OYS and AA) independently screened studies against the inclusion and exclusion criteria 
and performed the data extraction. Any disagreement over article inclusion, exclusion or data extraction 
between the two initial reviewers was resolved through a final assessment by a third reviewer (DA). As 
we already employed a two-stage search and extraction process based on a combination of independent 
review and reassessment, we did not calculate Kappa statistics to determine agreement between the re-
viewers. We extracted data and relevant information systematically from each study. This included loca-
tion, period, design, cancer registry, confirmation of diagnosis, data collation methods, coding criteria, 
data ascertainment and modality with which population or person years at risk were generated. The ba-
sic numerical data extracted were mean age (or age range), population or person years at risk, cancer cas-
es, and crude incidence. For studies conducted on the same cancer registry over the same period, we se-
lected the first chronologically published study, and supplementary data from other studies were added 
to the selected paper. All extracted data were separated into hospital-based and population-based studies, 
further sorted based on different regions in Africa (central, east, north, south, and west), and stored in 
Excel 2013 (Microsoft Inc, Redmond, WA, USA).
Data analysis
From extracted crude incidence rates of breast cancer, we conducted a random effects meta-analysis (Der-
Simonian and Laird method) [23]. For studies not reporting population or person years at risk, we checked 
the UN population projections of the country for the study period and multiplied by the years covered. 
For sub-national populations, we applied the subnational population ratio to standardize the United Na-
tions (UN) projections of the country for the study period. Standard errors were estimated from the crude 
incidence rates and person years assuming a Poisson distribution. Crude meta-estimates and confidence 
intervals (expressed per 100 000 person-years) were pooled from individual crude incidence rates and 
reported by registry-type for the African continent, the African sub-regions, age groups, and the years 
2000 and 2015. I-squared (I2) statistics and subgroup (sensitivity) analysis were conducted to assess het-
erogeneity between studies. We conducted a meta-regression analysis (with age and year as confounders) 
to further check consistency of the data extracted and estimates reported for hospital-based and popula-
tion-based registries, respectively. All statistical analyses were conducted on Stata 13.1 (Stata Corp LP, 
College Station, TX, USA).
RESULTS
Systematic review
The literature search returned a total of 4648 studies. There were 4633 studies identified from the data-
bases—Medline (1035), EMBASE (2811), Global Health (733) and AJOL (54). 15 additional studies were 
identified from Google Scholar, IARC and WHO AFRO websites, and hand-searching of reference lists. 
A total of 2858 records remained after duplicates were excluded. After reviewing titles for relevance (ie, 
studies providing incidence of breast cancer in any African location), 2650 studies were excluded, giving 
a total of 208 full texts that were assessed. After applying the selection criteria, 167 studies were exclud-
ed. A total of 41 studies were finally retained for the review [24-64] (Figure 1).
Study characteristics
The 41 studies retained were conducted across 54 study sites (locations) in 22 African countries (Table 
2). West Africa had the highest number of study sites (16) with seven of these sites located in Nigeria. 
South Africa closely followed with 6 sites while others were Uganda and Tunisia (5 sites each), Morocco 
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each). In total, SSA had 36 sites (70%) while North Af-
rica had 18 sites (30%) (see Table 2 for details). Pop-
ulation-based registries accounted for 67% of all study 
sites. These population-based registries reported main-
ly active or passive case findings across referral hospi-
tals, pathology laboratories, and communities within 
the geographical remit of the cancer registry. Data were 
abstracted mostly from pre-designed pathology/labo-
ratory forms confirming breast cancer diagnosis, with 
all sites reporting morphological/histological verifica-
tion of the breast cancer cases. Mean age of study pop-
ulation ranged from 30.6 to 60.8 years (median 50.2 
years), with over 33% in the age group 30-49 years, 
and over 81% in 30-59 years (Table 2).
Following the quality assessment, 23 (56%) studies 
were graded high, of which (20) 87% were conducted 
in population-based registries, which suggests the in-
ternal consistency and validity of these registries. How-
ever, most hospital-based studies were of moderate 
quality, as 15 (83%) of the total 18 studies graded mod-
erate were conducted in hospital-based registries (Fig-
ure 2, Table 2, Table S1 in Online Supplementary 
Document). The basic limitations of many hospi-
tal-based registries were related to poorly defined data 
collation and ascertainment process. Moreover, catch-
ment areas were also not well-defined, with this affect-
ing the estimation of person-years across these regis-
tries.
Pooled crude incidence rate of breast 
cancer in Africa
Population-based registries
From population-based registries (36 study sites), the 
overall pooled crude incidence of breast cancer in Af-
rica was 24.5 per 100 000 person years (95% Confi-
dence Interval [CI]: 20.1-28.9) (Figure 3, plate A). The 
incidence rate in North Africa was higher at 29.3 per 
100 000 (95% CI 20.0-38.7) than the pooled rates in 
SSA at 22.4 per 100 000 (95% CI 17.2-28.0). The es-
timated incidence rates in East Africa and West Africa 
were also relatively higher at 28.0 (95% CI 21.7-33.7) 
and 24.2 (95% CI 15.4-33.0) per 100 000, respective-
ly. Southern Africa had a pooled rate of 19.0 (95% CI 
10.1-27.8), while Central Africa had the lowest pooled 
incidence rates at 13.4 (95% CI 7.2-34.1) per 100 000. 
Due to high heterogeneity across studies (99.9%), we also reported the median incidence of breast can-
cer from all population-based registries, estimated at 28.1 per 100 000, with an interquartile range (IQR) 
of 18.6-31.3 per 100 000 (Table 3, Figure 2). Besides, a sensitivity analysis based on quality criteria 
showed studies graded as high quality had almost similar pooled incidence as the overall pooled inci-
dence at 24.3 per 100 000 person years (95% CI 19.9-28.8), compared to moderate quality studies at 
26.1 per 100 000 (95% CI 5.5-46.7) (Figure 3, plate B).
Moreover, in the population-based registries, we observed an increasing incidence with increasing age of 
subjects and over the study period covered (Table 3). The pooled incidence rate was highest among per-
sons older than 60 years at 36.6 per 100 000 (95% CI 30.7-42.4) compared to an incidence rate of 3.3 
per 100 000 (95% CI 2.7-3.8) among persons aged 30-39 years (Table 3). Between 2000 and 2015, the 
Figure 1. PRISMA flowchart of search strategy.
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Figure 3. A. Pooled crude incidence rates of breast cancer in Africa by African region – population-based cancer registries. B. Pooled 
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pooled incidence rate increased from 23.1 (95% CI 18.7-27.5) to 26.3 (95% CI 18.8-33.7) per 100 000, 
respectively (Table 3). Further analysis by region revealed incidence of breast cancer in North Africa in-
creased from 24.3 per 100 000 (95% CI 16.1-32.5) to 43.6 per 100 000 (95% CI 28.3-58.9) between 
2000 and 2015. However, the incidence was about the same over the same period in SSA at 22.6 per 
100 000 (95% CI 14.6-30.5) and 22.3 per 100 000 (95% CI 16.7 -27.9) (Table 3).
The meta-regression analysis showed a significant association of the crude incidence rates with age and 
year (P = 0.0012) (Table 4), which possibly demonstrates a relative consistency and representativeness of 
the data captured by population-based cancer registries. Assuming our pooled population-based registry 
estimates accounted for population growth, ageing and other demographic and epidemiological changes 
in Africa, these rates would account for 93 890 (95% CI 76 007-111,774) breast cancer cases among wom-
en in 2000. This increased to 150 526 breast cancer cases by 2015 (95% CI 107 600-192,880), based on 
the UN demographic projections for Africa.
Hospital-based registries
The results from the hospital-based registries (18 study sites) were slightly different (from the popula-
tion-registries (Figure 4, plate A; Table 3). The overall pooled crude incidence rate was estimated at 23.6 
per 100 000 (95% CI 18.5-28.7), with a median incidence of 15.0 per 100 000 (IQR: 5.0-47.9). Further 
sensitivity analysis showed high quality studies had a pooled incidence rate at 17.4 per 100 000 (95% CI 
2.2-32.5) compared to 25.4 per 100 000 (95% CI 19.8-31.0) for moderate quality hospital-based studies 
(Figure 4, plate B).
In contrast to the regional pattern observed in the population-based registries, SSA and Northern Africa 
had quite similar pooled rates at 24.0 per 100 000 (95% CI 17.5-30.4) and 23.2 per 100 000 (95% CI 
6.6-39.7), respectively. Central Africa also had the lowest incidence rate at 4.4 per 100 000 (95% CI 3.1-
5.7) (Figure 4, plate A). Although pooled incidence rates increased from 19.7 per 100 000 (95% CI 15.2-
24.2) to 36.9 per 100 000 (95% CI 4.1-69.6) between 2000 and 2015, this increase in incidence rates 
was not associated with advancing age (Table 3). Further analysis by region over the same period (2000-
2015) showed that North Africa and SSA markedly increased from 13.1 per 100 000 (95% CI 4.6-30.8) 
to 33.2 per 100 000 (95% CI 6.7-73.1), and 21.9 per 100 000 (95% CI 15.4-28.3) to 47.9 per 100 000 
(95% CI 41.2-54.6), respectively. However, incidence rates decreased sharply between ages 30-39 years 
Table 3. Sub-group meta-analysis of breast cancer crude incidence rates in Africa
headiNgS data
populatioN-baSed regiStry hoSpital-baSed regiStry











24.5 (20.1-29.0); high 
quality 24.3 (19.9-28.8)
99.9% (P <0.001) 36
23.6 (18.5-28.7); high 
quality 17.4 (2.2-32.5)





22.4 (17.2-28.0) 99.9% (P = <0.001) 25 24.0 (17.5-30.4) 99.3% (P = <0.001) 12
Central Africa 13.4 (7.2-34.1) 99.8% (P = <0.001) 2 4.4 (3.1-5.7) – 1
East Africa 28.0 (21.7-33.7) 98.8% (P = <0.001) 7 - – -
Southern Africa 19.0 (10.1-27.8) 100% (P = <0.001) 9 19.4 (6.3-32.5) 95.7% (P = <0.001) 2
West Africa 24.2 (15.4-33.0) 99.6% (P = <0.001) 7 27.4 (18.6-36.2) 99.4% (P = <0.001) 9
North Africa 29.3 (20.0-38.7) 99.5% (P = <0.001) 11 23.2 (17.0-29.5) 99.9% (P = <0.001) 6
Age
30-39 3.3 (2.7-3.8) 98.7% (P = <0.001) 2 23.3 (17.0-29.5) 99.7% (P = <0.001) 4
40-49 22.4 (13.1-31.7) 99.6% (P = <0.001) 7 7.1 (4.6-9.6) 91.3% (P = <0.001) 5
50-59 22.6 (18.6-26.6) 99.7% (P = <0.001) 19 34.3 (17.6-51.0) 99.5% (P = <0.001) 7




23.1 (18.7-27.5); North 
Africa 24.3 (16.1-32.5); 
SSA 22.6 (14.6-30.5)
99.7% (P = <0.001) 20
19.7 (15.2-24.2); North 
Africa 13.1 (4.6-30.8); 
SSA 21.9 (15.4-28.3)
99.6% (P = <0.001) 14
2010-2015
26.3 (18.8-33.7); North 
Africa 43.6 (28.3-58.9); 
SSA 22.3 (16.7-27.9)
99.9% (P = <0.001) 16
36.9 (4.1-69.6); North 
Africa 33.2 (6.7-73.1); 
SSA 47.9 (41.2-54.6)
99.7% (P = <0.001) 4
Median (Interquartile range) 28.1 (18.6-31.3) – 36 15.0 (5.0-47.9) – 18
CI – confidence interval
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Figure 4. A. Pooled crude incidence rates of breast cancer in Africa by African region – hospital-based cancer 
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and 40-49 years from 23.3 (95% CI 17.0-29.5) to 7.1 (95% CI 4.6-9.6) per 100 000; peaked at 50-59 
years (34.3 per 100 000, 95% CI 17.6-51.0), but dropped again at age 60 years and above to 27.1 per 
100 000 (95% CI 7.3-47.0) (Table 3). The meta-regression showed no significant relationship between 
incidence, age and years covered (P = 0.3926) (Table 4), which perhaps reflects incomplete data capture 
in the hospital registries (no data from East Africa), and is probably partly due to our inability to appro-
priately define the catchment area of the hospital.
DISCUSSION
As the leading cause of cancer globally among women, breast cancer has continued to attract interest 
among experts and clinicians, particularly towards appropriately quantifying its burden and identifying 
risks across countries. In Africa, experts have continued to work towards addressing several challenges 
in the response to a growing cancer burden [14]. However, with relatively scant, incomplete, or poorly 
representative data on cancer in many settings, it remains difficult to effectively address this burden [15]. 
This study provides the first systematic review and meta-analysis of publicly available evidence on the 
incidence of female breast cancer in Africa with a view to improving the understanding of the epidemi-
ology of the disease in the region. This endeavor yielded some findings.
Our study showed that population-based cancer registries remain the main sources of data on breast can-
cer in Africa as these provided 67% of data in this study. Current data from most hospital-based cancer 
registries are rather too incomplete and inconsistent to be deployed in the understanding of cancer epi-
demiology in Africa [12], as evidenced from the quality assessment. In the population-based registries, 
we observed that the estimated regional variation in breast cancer incidence in Africa was consistent with 
the GLOBOCAN 2008 and 2012 studies, with the incidence in North Africa higher than observed in SSA 
[6,9]. The estimated incidence of breast cancer in North Africa (29.3 per 100 000) was almost same as 
values reported by the global burden of diseases (GBD) collaborators for the region (29.7 per 100 000) 
[2]. However, the GBD collaborators noted a relatively higher incidence rate in SSA in 2015 at 34.1 per 
100 000 compared to our estimate of 22.4 per 100 000 (95% CI 17.2-28.0) for SSA [2]. The GBD esti-
mates are thus suggestive of a higher incidence of breast cancer in SSA compared to North Africa, which 
are in contrast to our findings of the opposite, and possibly raises potential questions regarding the rising 
trend of breast cancer in SSA compared to North Africa. The differences may be partly attributable to 
sources and completeness of data, as well as modeling approaches employed in the GBD estimates com-
pared to the present study. Although some previous reports have shown that the estimated incidence rates 
of breast cancer across North African states are higher than in SSA, and comparable to rates in some 
high-income settings [65-67]. The regional differences in Africa may be indicative of racial and ethnic 
disparities in invasive breast cancer epidemiology in the region, as already observed in the variations in 
incidence and mortality patterns between black and white women globally [68,69]. Dickens and col-
leagues noted that the clinical spectrum of breast cancer in Africa is highly heterogenous across popula-
tion groups [70], with this often linked to variations in age at diagnosis, staging, time trends, and genet-
Table 4. Meta-regression analysis by registry type
breaSt caNcer iNcideNce coef. Std. err. t p > t upper ci lower ci
Population-based*
Age 8.718566 2.188229 3.98 <0.001 4.26658 13.17055
Year 3.975006 3.495557 1.14 0.264 -3.136759 11.08677
_cons 6.098437 4.850205 1.26 0.217 -3.769378 15.96625
Hospital-based†
Age 1.865169 6.001334 0.31 0.760 -10.92637 14.65671
Year 14.49101 13.73779 1.05 0.308 -14.79038 43.77241
_cons -10.83332 27.9259 -0.39 0.704 -70.35596 48.68932
CI – confidence interval
*Number of observations = 36. REML estimate of between-study variance (tau2) = 105.9. % residual variation due to heterogeneity 
(I-squared_res) = 99.56%. Proportion of between-study variance explained (Adj R-squared) = 29.96%. Joint test for all covariates 
Model F(2,33) = 8.34. With Knapp-Hartung modification Prob>F = 0.0012.
Number of observations = 18
†REML estimate of between-study variance (tau2) = 443.7. % residual variation due to heterogeneity (I-squared_res) = 99.43%. Pro-
portion of between-study variance explained (Adj R-squared) = 0.09%. Joint test for all covariates Model F(2,15) = 1.00. With 
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ic and environmental risks [69,71]. Moreover, the different stages of fertility transition currently observed 
in Africa as evidenced by declining births and widening birth intervals across population groups may also 
be an important driver of the regional differences [71].
Across both population- and hospital-based registries, we reported lower incidence rates in Central Afri-
ca. However, these estimates have wide uncertainty intervals, possibly reflecting the limited data in the 
region, and the substantial variation and imprecision in reported figures already noted across African 
countries [10,72]. Some authors have reported the lack of data in Central Africa as a major factor miti-
gating against the estimation of disease burden and ensuring evidence-based interventions in the region 
[12,73,74]. Balekouzou and colleagues specifically noted that the epidemiology of breast cancer in Cen-
tral Africa remain poorly understood, owing to sparse data on cancer in the region [75]. Ongoing civil 
unrest in some parts of Central Africa influencing the capacity of the health systems to adequately capture 
cancer cases may have resulted in a relatively low cancer ascertainment.
The mean age of populations covered in both the population- and hospital-based registries ranged from 
30.6 to 60.8 years (median 50.2 years), with over 33% and 81% of population in ages 30-49 years, and 
30-59 years, respectively. This, albeit subject to further validations, may be suggestive of a high incidence 
of breast cancer among younger age groups in Africa. For example, Jedy-Agba and colleagues reported 
that many cases of breast cancer in SSA were diagnosed in the ages 35-49 years, with many presenting at 
advanced late-stage cancer [7]. Some authors have argued that the higher proportion of younger women 
in Africa, due to a relatively lower life expectancy on the continent, may have been responsible for the 
increasing breast cancer incidence reported among younger age groups [14,76]. However, epidemiolog-
ical transitions, rapid urbanization with increased adoption of unhealthy lifestyles, increasing prevalence 
of obesity in younger populations, changing reproductive behaviours, including early menarche, low par-
ity, advanced age at first pregnancy, and low self-breast examination for breast cancer among adolescents 
and young women have been identified as possible risk factors [14,76,77].
The poor state of many health systems in Africa and their declining capacity to lead cancer preventive 
initiatives and response to overall health needs of the population, as compared to developed countries, 
are also major concerns. Abdulrahman and Rahman reported that there are significant differences in age 
and stage at presentation between women in Africa and Europe, with more than half of breast cancer pa-
tients in Nigeria and Libya presenting at relatively younger age, mostly with advanced stage III or IV dis-
ease [78]. Parkin et al. equally noted that the lifetime risk of dying from breast cancer in young African 
women is about twice the risk in high-income countries [56].
Meanwhile, we observed some important variations in the estimates reported from population-and hos-
pital-based registries in this study. Although our estimated incidence of breast cancer increased between 
2000 and 2015 in both registries, suggestive of a rising breast cancer incidence in Africa, there was how-
ever a more significant rise in breast cancer incidence with advancing age in the population-based regis-
tries. This was clearly different from our finding from the hospital-based studies. Moreover, from popu-
lation-based registries, the breast cancer incidence in North Africa (29.7 per 100 000) was higher than 
the incidence in SSA (22.4 per 100 000), while hospital-based registries provided relatively similar esti-
mates (23.2 per 100 000 vs 24.0 per 100000). These variations, notwithstanding our estimation approach, 
further raise concerns on the completeness and representativeness of data in African registries. Popula-
tion-based cancer registries have been widely regarded as being the gold standard for accurate data col-
lation on cancer [79], as they cover wide geographical areas including communities, and employ standard 
coding methods and estimation of person-years [12]. However, challenges have been identified in the 
establishment and effective functioning of population-based registries across Africa due to poor funding, 
lack of skilled personnel, and low priorities from many governments, with this affecting the estimates 
provided [12,79]. Some authors have reported that hospital-based registries can indeed complement the 
few population-based registries, particularly by providing data on health service provision and access, 
which is useful for appropriate planning and public health response [79]. To address challenges with data 
consistency and representativeness, efforts may also be directed at improving geographical mapping of 
hospitals to appropriately determine the catchment area or population covered, and generate standard-
ized methods to calculate cancer incidence that are representative of the population [12].
The application of precision medicine across world regions is still evolving [3]. However, translating this 
into prevention and management of breast cancer in Africa also requires additional efforts with cancer 
registration [3]. It is important for future research to decipher if the advanced stage of breast cancer pre-
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some specific intrinsic host factors in African populations [7,76]. This is essential to guide health care 
practitioners to adequately respond to known and prevailing health disparities with respect to genetic 
determinants, predisposition and susceptibility to breast cancer across different ethnic groups on the con-
tinent [3]. However, the research capacity in this regard is relatively poor, and additionally limited by the 
lack of comprehensive and nationally representative data on breast cancer across African countries [5]. 
Hence, public health promoting behaviors that decrease breast cancer incidence still appears be most im-
portant and feasible preventive strategy across Africa.
The limitations of this study are also related to our key findings. First, though we performed a compres-
sive data retrieval process, the empirical estimates we provided are limited by the absence of popula-
tion-based cancer registries in many African countries (only 22 African countries represented), which has 
implications for the precision and representativeness of our estimates. Although, about 67% of studies 
were conducted in population-based cancer registries, many of these registries only covered subnational 
populations. As highlighted in the results, Nigeria and South Africa had the highest data points in this 
study. However, of all entries, South Africa particularly provided a complete national registry report of 
histologically-diagnosed breast cancer cases covering a period of 18 years, although only recent reports 
suggested an upgrade to population-based cancer registration system [80]. As noted, across data from 
hospital-based reports, we relied on the UN demographics for the country to estimate reference popula-
tions and person-years when they were not provided. This could have led to a relative under-estimation 
of cancer incidence due to resultant large denominators derived from the UN demographics. Besides, es-
timates were not age-standardized which limits direct comparisons with other world regions. Moreover, 
the heterogeneity across selected studies was high (I2>90%), which further reflects the need to address 
varying study designs, case ascertainments, referral approaches, and standards for collation of cancer data 
across different population groups, as these are important sources of heterogeneity. Despite these limita-
tions, it is still important to present to the public the challenges arising from data availability on breast 
cancer research in Africa, the varying estimates available, and the implication of this on the response to a 
rising burden of breast cancer on the continent.
CONCLUSIONS
The efforts of various researchers and organizations, particularly the IARC, United States National Cancer 
Institute (NCI) and African Organization for Research and Training in Cancer (AORTIC), must be ac-
knowledged in the response to cancer in Africa. Data availability remains an ongoing limitation in under-
standing and estimating the incidence of breast cancer on the continent. Further issues from available 
data include inconsistency in data collation and quality across existing cancer registries. However, avail-
able evidence is suggestive of a growing incidence of breast cancer in Africa. With population growth and 
ageing, exposures to known risks, and relative weak health systems in Africa, it is unlikely this trend will 
change in the short-term in the absence of effective interventions, with this further straining the health 
system in many African countries. As various funders and institutions develop their focuses, we assert 
that strategies for controlling and treating breast cancer patients must include activities that support ac-
tive and comprehensive data collation and cancer registration (population- and hospital-based) on the 
African continent, and more emphasis on the biological and histological characteristics of breast cancer 
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